USFDA concludes inspection at Zydus Cadila’s API manufacturing facilities in Ankleshwar

27 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has inspected the Zydus Cadila’s API manufacturing facility located at Ankleshwar in Gujarat. The inspection was conducted from July 22, 2019 to July 26, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

430.25 4.15 (0.97%)
27-Jan-2023 18:01 View Price Chart
Company Name CMP
Sun Pharma Inds. 1043.60
Cipla 1047.05
Dr. Reddys Lab 4318.30
Lupin 742.20
Zydus Lifesciences 430.25
View more..